Cutaneous Reactions Following Virus Infections and Antiviral Vaccines
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "General Virology".
Deadline for manuscript submissions: 15 May 2024 | Viewed by 846
Special Issue Editors
Interests: hidradenitis suppurativa; psoriasis; atopic dermatitis; new treatment; skin inflammatory disease
Special Issues, Collections and Topics in MDPI journals
Interests: Covid19; Covid19-vaccine; hidradenitis suppurativa; psoriasis; atopic dermatitis; lichen planus; skin inflammatory disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The outbreak of coronavirus disease 2019 (COVID-19) represented a new worldwide challenge, strongly impacting the global economy, overall health and lifestyle. Since then, several strategies have been adopted to contain the widespread of infection. Among these, vaccination is currently the most important measure to fight against the pandemic. However, several concerns such as slower-than-hoped-for rollout, the hurried approval with limited data, the mechanism of action (in particular mRNA-based), and the uncertain duration of protection they afforded were initially raised. Moreover, even if cutaneous reactions have been rarely reported in clinical trials, global mass vaccination showed several dermatologic reactions that were not initially recognized, leaving dermatologists to decide how to diagnose and treat them. Dermatologists should be ready to promptly recognize these clinical manifestations. The aim of this Special Issue is to help clinicians to better understand these dermatological conditions and to provide an extensive overview of all vaccine-related skin manifestations.
Dr. Fabrizio Martora
Dr. Angelo Ruggiero
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- COVID-19 vaccine
- hidradenitis suppurativa
- psoriasis
- atopic dermatitis
- lichen planus
- skin inflammatory disorders
